Fig. 6. (a) In vivo fluorescence imaging of A431-tumour-bearing BALB/c mice at different time points injected with 100 μL of EBD-1 (10−3 M/200 mm3). (b) Fluorescence intensity of EBD-1 in the tumour. (c) Fluorescence images of harvested tumours and major organs at 24 h of the experiment. (d) Fluorescence intensity of tumours and major organs after 24 h of the experiment.
